One of the most interesting things I’ve come across while reading some DePuy ASR Hip Replacement recall message boards is that many hip replacement patients don’t seem to even know what hip implant they received. The upshot of that is that, at the least, they have no clue what’s been put inside their bodies, and at the worst, if there is a problem with the implanted medical device, they may not know it—or news of such must rely on a string of communications from manufacturer to health provider to patient—and that’s if you’re lucky.
So news of the DePuy hip implant recall may—or may not—have reached those who actually have received the ASR hip replacement—and that’s not an ideal situation for such a serious recall.
The DePuy hip replacement recall was for about 93,000 units of the DePuy ASR Hip (manufactured by DePuy Orthopaedics). While some online reports were suggesting that upwards of 80,000 DePuy ASR Hip patients may ultimately need hip replacement revision surgery, studies have been done that suggest the rate of hip revision surgery is more in the range of 12-13%—meaning that one in twelve to thirteen DePuy Hip patients may well need hip revision surgery within five years of having their initial DePuy hip replacement surgery.
So if you’re one of those patients—one of the 12-13%–how would you know it?
From actual reader comments, it sounds like one of the main symptoms is the inability to squat—at least not to the full range that you should be able to post-surgery and post-therapy. There have also been first-hand reports of things like still using crutches for much longer than the usual timeframe anticipated post-hip replacement surgery. But the main signs to look for—those that appear to be consistent among patients with a defective DePuy ASR hip implant are these:
Given that DePuy lawsuits have been filed, and that seeking legal help may be the only way for someone who’s received a defective DePuy hip replacement to ensure that they get any damages that may be awarded to them, if you’ve had hip replacement surgery and are experiencing any of the above symptoms and they don’t appear to be going away, you should first contact your doctor and/or surgeon to find out the manufacturer and make of the hip implant you received. If it was indeed the DePuy ASR hip, you should most likely speak with an attorney who specializes in DePuy hip lawsuits.
If finding the right medication feels a bit like a minefield lately, it’s no wonder.
It’s not been a banner time for Pharma—these past few years. So many drugs and medical products in general seem to be linked with serious, if not life-threatening adverse events. You may recognize some of the names on the hit parade: drugs such as Accutane and a possible link with inflammatory bowel disease (IBD); proton pump inhibitors (antacid drugs) and increased risk for hip fractures; Reglan and its link with Tardive Dyskinesia; Byetta—a diabetes medication linked with kidney failure…
And of course no list would be complete without Avandia—another diabetes medication—and its infamous association with serious, sometimes fatal cardiovascular events.
Oh—there’s also allegations surrounding the class of antidepressants known as SSRIs and links with newborn heart defects. In fact the list is exhaustive.
And to be clear, it’s not just drugs. Products such as the DePuy metal hip replacement are also in trouble. DePuy is currently facing a class action lawsuit over failure rates seen with its ASR acetabular cup. DePuy, which is owned by Johnson & Johnson, has also had global product recalls.
Gadolinium is another one. It’s a clear, non-radioactive chemical compound used with patients undergoing magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA). In 1988 the FDA approved gadolinium as a contrast agent to provide a clearer picture of organs and tissues. Since that time, more than 200 cases of Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD) have been linked to the product.
This week, news out on Bloomberg indicates that the powers that be at Pfizer Inc, ‘failed to properly warn doctors and consumers that its Prempro menopause drug could cause Read the rest of this entry »